Medical Biochemistry and Molecular Biology, Saarland University, 66421 Homburg, Germany.
Int J Mol Sci. 2023 Sep 15;24(18):14166. doi: 10.3390/ijms241814166.
To elucidate the redundancy in the components for the targeting of membrane proteins to the endoplasmic reticulum (ER) and/or their insertion into the ER membrane under physiological conditions, we previously analyzed different human cells by label-free quantitative mass spectrometry. The HeLa and HEK293 cells had been depleted of a certain component by siRNA or CRISPR/Cas9 treatment or were deficient patient fibroblasts and compared to the respective control cells by differential protein abundance analysis. In addition to clients of the SRP and Sec61 complex, we identified membrane protein clients of components of the TRC/GET, SND, and PEX3 pathways for ER targeting, and Sec62, Sec63, TRAM1, and TRAP as putative auxiliary components of the Sec61 complex. Here, a comprehensive evaluation of these previously described differential protein abundance analyses, as well as similar analyses on the Sec61-co-operating EMC and the characteristics of the topogenic sequences of the various membrane protein clients, i.e., the client spectra of the components, are reported. As expected, the analysis characterized membrane protein precursors with cleavable amino-terminal signal peptides or amino-terminal transmembrane helices as predominant clients of SRP, as well as the Sec61 complex, while precursors with more central or even carboxy-terminal ones were found to dominate the client spectra of the SND and TRC/GET pathways for membrane targeting. For membrane protein insertion, the auxiliary Sec61 channel components indeed share the client spectra of the Sec61 complex to a large extent. However, we also detected some unexpected differences, particularly related to EMC, TRAP, and TRAM1. The possible mechanistic implications for membrane protein biogenesis at the human ER are discussed and can be expected to eventually advance our understanding of the mechanisms that are involved in the so-called Sec61-channelopathies, resulting from deficient ER protein import.
为了阐明在生理条件下将膜蛋白靶向内质网(ER)和/或插入 ER 膜的组件的冗余性,我们之前通过无标记定量质谱分析了不同的人类细胞。通过 siRNA 或 CRISPR/Cas9 处理使 HeLa 和 HEK293 细胞耗尽了特定的成分,或使缺乏特定成分的患者成纤维细胞与相应的对照细胞进行差异蛋白丰度分析。除了 SRP 和 Sec61 复合物的客户外,我们还鉴定了 ER 靶向的 TRC/GET、SND 和 PEX3 途径的膜蛋白客户,以及 Sec62、Sec63、TRAM1 和 TRAP 作为 Sec61 复合物的假定辅助成分。在这里,我们对这些之前描述的差异蛋白丰度分析进行了全面评估,以及对 Sec61 合作的 EMC 和各种膜蛋白客户的拓扑序列特征(即组件的客户谱)的类似分析进行了报道。正如预期的那样,该分析将具有可切割的氨基末端信号肽或氨基末端跨膜螺旋的膜蛋白前体鉴定为 SRP 以及 Sec61 复合物的主要客户,而具有更中心甚至羧基末端的前体则被发现主导 SND 和 TRC/GET 途径的膜靶向客户谱。对于膜蛋白插入,辅助 Sec61 通道组件确实在很大程度上共享 Sec61 复合物的客户谱。然而,我们还检测到一些意外的差异,特别是与 EMC、TRAP 和 TRAM1 有关。讨论了内质网中膜蛋白生物发生的可能机制意义,并有望最终提高我们对涉及所谓 Sec61 通道病的机制的理解,这些疾病是由于内质网蛋白导入缺陷引起的。